Sort   by:  
 Page size 
UnknownLong-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study.
Not available
S-EPMC4404424 | biostudies-literature
UnknownThe Nature of Metastable AA' Graphite: Low Dimensional Nano- and Single-Crystalline Forms.
Not available
S-EPMC5175192 | biostudies-literature
ProteomicsHuman Immunoglobulin Repertoire-Guided Immunogen Design Targeting HIV V2-Apex Broadly Neutralizing Antibody Precursors
Broadly neutralizing antibodies (bnAbs) to the HIV envelope (Env) V2-apex region are important leads for HIV vaccine design. Most V2-apex bnAbs engage Env with an uncommonly long heavy chain complementarity-determining region 3 (HCDR3), suggesting that rarity of bnAb precursors poses a challenge for...
ORGANISM(S): Homo sapiens (Human) Human immunodeficiency virus 
2023-03-11 | PXD033766 | Pride
Hiv antibodies Aids vaccines Structural vaccinology Immunoinformatics 
UnknownRandomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).
Not available
S-EPMC4622102 | biostudies-literature
UnknownEvolution of the EKA family of powdery mildew avirulence-effector genes from the ORF 1 of a LINE retrotransposon.
Not available
S-EPMC4641428 | biostudies-literature
UnknownRacial disparities in survival among women with endometrial cancer in an equal access system.
Not available
S-EPMC8562590 | biostudies-literature
ProteomicsIFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma: Phosphoproteomics
Chimeric antigen receptor (CAR) T cell therapies have revolutionized B cell malignancy treatment, but subsets of patients with large B cell lymphoma (LBCL) experience primary resistance or relapse after CAR T cell treatment. To uncover tumor microenvironment (TME)-induced resistance mechanisms, we e...
ORGANISM(S): Mus musculus (Mouse) 
2026-05-30 | PXD079082 | Pride
Macrophages B cell lymphoma Interferon Inos Chimeric antigen receptor t cell 
ProteomicsIFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma
Chimeric antigen receptor (CAR) T cell therapies have revolutionized B cell malignancy treatment, but subsets of patients with large B cell lymphoma (LBCL) experience primary resistance or relapse after CAR T cell treatment. To uncover tumor microenvironment (TME)-induced resistance mechanisms, we e...
ORGANISM(S): Mus musculus (Mouse) 
2026-05-30 | PXD079073 | Pride
Macrophages B cell lymphoma Interferon Inos Chimeric antigen receptor t cell 
UnknownMolecular markers for tracking the origin and worldwide distribution of invasive strains of Puccinia striiformis.
Not available
S-EPMC4800029 | biostudies-literature
MetabolomicsMultiplatform serum metabolic phenotyping combined with pathway mapping to identify biochemical differences in smokers (NMR assay)

A multiplatform comparison of serum of smokers (n=56) and non-smokers (n=57) using NMR spectroscopy and UPLC-MS was carried out to determine perturbed biochemical functions associated with tobacco smoking. This should be helpful for establishing causal relationships between exposure and adverse e...

2017-01-09 | MTBLS374 | MetaboLights
Sort   by:  
 Page size